Cas:82977-45-5 5-oxooxolane-2-carbonyl chloride manufacturer & supplier

We serve Chemical Name:5-oxooxolane-2-carbonyl chloride CAS:82977-45-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-oxooxolane-2-carbonyl chloride

Chemical Name:5-oxooxolane-2-carbonyl chloride
CAS.NO:82977-45-5
Synonyms:tetrahydro-5-oxofuran-2-carboxylic acid chloride;5-oxo-2-tetrahydrofuran carbonyl chloride;2-Furancarbonyl chloride,tetrahydro-5-oxo;5-oxotetrahydro-2-furancarbonyl chloride;5-oxotetrahydrofuran-2-carbonyl chloride
Molecular Formula:C5H5ClO3
Molecular Weight:148.54400
HS Code:2932190090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.37000
Exact Mass:147.99300
LogP:0.45740

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like tetrahydro-5-oxofuran-2-carboxylic acid chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-oxotetrahydrofuran-2-carbonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tetrahydro-5-oxofuran-2-carboxylic acid chloride Use and application,2-Furancarbonyl chloride,tetrahydro-5-oxo technical grade,usp/ep/jp grade.


Related News: In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 5-oxooxolane-2-carbonyl chloride manufacturer APIs are generally manufactured through a variety of processes that include. 5-oxooxolane-2-carbonyl chloride supplier In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 5-oxooxolane-2-carbonyl chloride vendor They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. 5-oxooxolane-2-carbonyl chloride factory Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly.